查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1555695

核心臨床分子診斷市場，按產品類型、技術、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Core Clinical Molecular Diagnostics Market, By Product Type, By Technology, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 370 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年核心臨床分子診斷市場規模為51.2412億美元，2024年至2032年複合年成長率為9.65%。

核心臨床分子診斷市場-市場動態

慢性病負擔的上升推動了核心臨床分子診斷市場的擴張

癌症、糖尿病和心血管疾病等慢性疾病的盛行率不斷上升，大大增加了對分子診斷的需求。根據世界衛生組織(WHO) 的數據，非傳染性疾病(NCD) 佔全球死亡人數的70% 以上，其中僅癌症一項就在2020 年造成近1000 萬人死亡。專注於早期檢測和精準醫療，推動了分子診斷的採用。例如，美國國立衛生研究院 (NIH) 強調了分子診斷在提高疾病診斷準確性和實現標靶治療（特別是在腫瘤學領域）方面的作用。人們越來越依賴分子診斷來管理慢性病，這凸顯了其在全球醫療保健領域不斷擴大的角色。

核心臨床分子診斷市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 9.65% 左右的複合年成長率成長

根據產品類型細分，預計試劑和試劑盒將在 2023 年顯示最大的市場佔有率

從技術細分來看，聚合酶鍊式反應是2023年的主導類型

按地區分類，北美是 2023 年的主要收入來源

核心臨床分子診斷市場-細分分析：

全球核心臨床分子診斷市場根據產品類型、技術、最終用戶和地區進行細分。

市場依產品類型分為三類：儀器、試劑和套件以及軟體和服務。試劑和試劑盒因其在診斷過程中的重要作用而具有最高優先順序。儀器密切追蹤，並提供測試所需的技術。軟體和服務至關重要，但處於次要地位，支援營運效率。

市場依技術分為兩大類：聚合酶鍊式反應、次世代定序、原位雜合技術、微陣列和等溫核酸擴增技術。聚合酶鍊式反應 (PCR) 由於其廣泛使用和可靠性而處於優先地位。新一代定序（NGS）因其先進的功能而緊隨其後，而原位雜合技術、微陣列和等溫核酸擴增技術（INAAT）則佔據了後續位置。

核心臨床分子診斷市場-地理洞察

核心臨床分子診斷市場在各個地區呈現多樣化的成長模式，其中北美由於其先進的醫療基礎設施、尖端技術的高度採用以及對精準醫療的高度重視而處於領先地位。尤其是美國，在研發方面的大量投資以及癌症和糖尿病等慢性病的高盛行率的推動下，在市場上佔據主導地位。歐洲緊隨其後，德國和英國等國家因其完善的醫療保健系統和不斷增加的支持分子診斷的政府舉措而做出了巨大貢獻。在醫療保健支出增加、診斷基礎設施改善以及早期疾病檢測意識不斷增強的推動下，亞太地區正在經歷快速成長。值得注意的是，中國和印度因其龐大的患者群體和不斷成長的個人化醫療需求而正在成為關鍵市場。同時，隨著拉丁美洲、中東和非洲地區醫療保健系統的不斷發展，儘管速度較慢，拉丁美洲和中東和非洲地區的發展勢頭正在逐漸增強。

核心臨床分子診斷市場-競爭格局：

羅氏診斷、雅培實驗室和賽默飛世爾科技等領先公司憑藉其廣泛的產品組合、強大的研發能力和全球分銷網路佔據了市場主導地位。例如，羅氏診斷公司透過其強大的基於 PCR 的診斷產品組合和策略收購（例如收購 Stratos Genomics）保持了競爭優勢。雅培實驗室專注於擴大其分子診斷產品，特別是在傳染病檢測方面，而賽默飛世爾科技則繼續利用定序和分子測定方面的先進技術進行創新。其他著名的參與者，包括 Hologic, Inc.、Qiagen NV 和 Bio-Rad Laboratories，也在透過新產品發布和合作方面取得了重大進展。新興新創公司和小型公司不斷推出顛覆性技術和新穎的診斷解決方案，從而推動老牌企業不斷增強其產品，從而進一步加劇了競爭格局。

最新進展：

2021年8月，BD為美國實驗室推出了全自動高通量分子診斷平台BD COR™系統。該系統透過自動化樣本處理和整合各種實驗室工作流程來提高子宮頸癌篩檢的效率，滿足診斷測試的重大需求。

2024 年 5 月，Northwell Health 在紐約成功湖開設了耗資 320 萬美元的分子診斷實驗室。該設施旨在增強包括 COVID-19 在內的各種疾病的檢測能力，並將支持衛生系統對先進診斷服務的承諾。

目錄

第 1 章：核心臨床分子診斷市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品類型分類的核心臨床分子診斷市場片段
    • 核心臨床分子診斷市場技術片段
    • 最終用戶的核心臨床分子診斷市場片段
    • 按國家/地區分類的核心臨床分子診斷市場片段
    • 按地區分類的核心臨床分子診斷市場片段
  • 競爭洞察

第 3 章：核心臨床分子診斷主要市場趨勢

  • 核心臨床分子診斷市場促進因素
    • 市場促進因素的影響分析
  • 核心臨床分子診斷市場限制
    • 市場限制影響分析
  • 核心臨床分子診斷市場機會
  • 核心臨床分子診斷市場未來趨勢

第 4 章：核心臨床分子診斷產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：核心臨床分子診斷市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：核心臨床分子診斷市場格局

  • 2023 年核心臨床分子診斷市佔分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：核心臨床分子診斷市場 - 按產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 儀器儀表
    • 試劑和試劑盒
    • 軟體與服務

第 8 章：核心臨床分子診斷市場 - 按技術分類

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 聚合酶鍊式反應 (PCR)
    • 新一代定序 (NGS)
    • 原位雜合技術
    • 微陣列
    • 等溫核酸擴增技術（INAAT）

第 9 章：核心臨床分子診斷市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院和診所
    • 診斷實驗室
    • 研究所
    • 學術機構

第 10 章：核心臨床分子診斷市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美核心臨床分子診斷主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按技術）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲核心臨床分子診斷主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區核心臨床分子診斷主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（按技術）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲核心臨床分子診斷主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按技術）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 核心臨床分子診斷中東和非洲主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按技術）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：關鍵供應商分析 - 核心臨床分子診斷產業

  • 競爭儀表板
  • 公司簡介
    • Abbott Laboratories
    • Agilent Technologies, Inc.
    • bioMerieux SA
    • Bio-Rad Laboratories, Inc.
    • Cepheid (A Danaher Company)
    • Danaher Corporation
    • Genomic Health, Inc. (Exact Sciences)
    • Hologic, Inc.
    • Illumina, Inc.
    • Luminex Corporation
    • Myriad Genetics, Inc.
    • PerkinElmer, Inc.
    • QIAGEN NV
    • Roche Diagnostics
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV3665

REPORT HIGHLIGHT

The Core Clinical Molecular Diagnostics Market size was valued at USD 5,124.12 million in 2023, expanding at a CAGR of 9.65% from 2024 to 2032.

The Core Clinical Molecular Diagnostics Market is centered around advanced techniques that analyze biological markers in the genome and proteome, facilitating precision medicine. The growing prevalence of chronic diseases, advancements in genetic sequencing technologies, and increasing demand for personalized medicine are key contributors to market growth. However, the high cost of molecular diagnostic tests and stringent regulatory requirements pose significant challenges. Opportunities abound in the expanding use of molecular diagnostics in emerging markets and the integration of AI for data analysis, which could revolutionize diagnostic accuracy. Notably, over 70% of clinical decisions are influenced by diagnostics, underscoring the critical role of molecular diagnostics in modern healthcare.

Core Clinical Molecular Diagnostics Market- Market Dynamics

Rising Chronic Disease Burden Fuels Expansion of Core Clinical Molecular Diagnostics Market

The rising prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular disorders, is significantly boosting the demand for molecular diagnostics. According to the World Health Organization (WHO), non-communicable diseases (NCDs) account for over 70% of all deaths globally, with cancer alone causing nearly 10 million deaths in 2020. This surge in chronic conditions has led to an increased focus on early detection and precision medicine, driving the adoption of molecular diagnostics. For instance, the National Institutes of Health (NIH) has highlighted the role of molecular diagnostics in improving the accuracy of disease diagnosis and enabling targeted therapies, particularly in oncology. This growing reliance on molecular diagnostics to manage chronic diseases underscores its expanding role in the global healthcare landscape.

Core Clinical Molecular Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.65% over the forecast period (2024-2032)

Based on product type segmentation, Reagents & Kits was predicted to show maximum market share in the year 2023

Based on Technology segmentation, Polymerase Chain Reaction was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Core Clinical Molecular Diagnostics Market- Segmentation Analysis:

The Global Core Clinical Molecular Diagnostics Market is segmented based on Product Type, Technology, End-User, and Region.

The market is divided into three categories based on product type: Instruments, Reagents & Kits, and Software & Services. Reagents and kits hold the highest priority due to their essential role in diagnostic procedures. Instruments are followed closely, and the necessary technology is provided for testing. Software and services are crucial but are secondary, supporting operational efficiency.

The market is divided into two categories based on Technology: Polymerase Chain Reaction, Next-Generation Sequencing, In Situ Hybridization, Microarray, and Isothermal Nucleic Acid Amplification Technology. Polymerase Chain Reaction (PCR) leads in priority due to its widespread use and reliability. Next-generation sequencing (NGS) follows for its advanced capabilities, while In Situ Hybridization, Microarray, and Isothermal Nucleic Acid Amplification Technology (INAAT) occupy subsequent positions.

Core Clinical Molecular Diagnostics Market- Geographical Insights

The Core Clinical Molecular Diagnostics Market exhibits diverse growth patterns across various regions, with North America leading due to its advanced healthcare infrastructure, high adoption of cutting-edge technologies, and strong focus on precision medicine. The United States, in particular, dominates the market, driven by significant investments in research and development, coupled with a high prevalence of chronic diseases like cancer and diabetes. Europe follows closely, with countries like Germany and the UK making substantial contributions due to their well-established healthcare systems and increasing government initiatives supporting molecular diagnostics. The Asia-Pacific region is experiencing rapid growth, fueled by rising healthcare expenditures, improving diagnostic infrastructure, and a growing awareness of early disease detection. Notably, China and India are emerging as key markets due to their large patient populations and increasing demand for personalized medicine. Meanwhile, Latin America and the Middle East & Africa regions are gradually gaining momentum, albeit at a slower pace, as healthcare systems in these areas continue to develop.

Core Clinical Molecular Diagnostics Market- Competitive Landscape:

Leading companies such as Roche Diagnostics, Abbott Laboratories, and Thermo Fisher Scientific dominate the market, leveraging their extensive product portfolios, strong R&D capabilities, and global distribution networks. Roche Diagnostics, for instance, has maintained a competitive edge through its robust portfolio of PCR-based diagnostics and strategic acquisitions, like the purchase of Stratos Genomics. Abbott Laboratories has focused on expanding its molecular diagnostics offerings, particularly in infectious disease testing, while Thermo Fisher Scientific continues to innovate with advanced technologies in sequencing and molecular assays. Other notable players, including Hologic, Inc., Qiagen N.V., and Bio-Rad Laboratories, are also making significant strides through new product launches and collaborations. The competitive landscape is further intensified by emerging startups and smaller firms that are introducing disruptive technologies and novel diagnostic solutions, pushing established players to continuously enhance their offerings.

Recent Developments:

In August 2021, BD launched a fully automated high-throughput molecular diagnostic platform, the BD COR(TM) System, for U.S. laboratories. This system enhances efficiency in cervical cancer screening by automating sample processing and integrating various laboratory workflows, addressing significant needs in diagnostic testing.

In May 2024, Northwell Health inaugurated a USD 3.2 million molecular diagnostics laboratory in Lake Success, New York. The facility aims to enhance testing capabilities for various diseases, including COVID-19 and will support the health system's commitment to advanced diagnostic services.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CORE CLINICAL MOLECULAR DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Cepheid (A Danaher Company)
  • Danaher Corporation
  • Genomic Health, Inc. (Exact Sciences)
  • Hologic, Inc.
  • Illumina, Inc.
  • Luminex Corporation
  • Myriad Genetics, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Roche Diagnostics
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Others

GLOBAL CORE CLINICAL MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Instruments
  • Reagents & Kits
  • Software & Services

GLOBAL CORE CLINICAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Polymerase Chain Reaction (PCR)
  • Next-Generation Sequencing (NGS)
  • In Situ Hybridization
  • Microarray
  • Isothermal Nucleic Acid Amplification Technology (INAAT)

GLOBAL CORE CLINICAL MOLECULAR DIAGNOSTICS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Academic Institutions

GLOBAL CORE CLINICAL MOLECULAR DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Core Clinical Molecular Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Core Clinical Molecular Diagnostics Market Snippet by Product Type
    • 2.1.2. Core Clinical Molecular Diagnostics Market Snippet by Technology
    • 2.1.3. Core Clinical Molecular Diagnostics Market Snippet by End-User
    • 2.1.4. Core Clinical Molecular Diagnostics Market Snippet by Country
    • 2.1.5. Core Clinical Molecular Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Core Clinical Molecular Diagnostics Key Market Trends

  • 3.1. Core Clinical Molecular Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Core Clinical Molecular Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Core Clinical Molecular Diagnostics Market Opportunities
  • 3.4. Core Clinical Molecular Diagnostics Market Future Trends

4. Core Clinical Molecular Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Core Clinical Molecular Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Core Clinical Molecular Diagnostics Market Landscape

  • 6.1. Core Clinical Molecular Diagnostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Core Clinical Molecular Diagnostics Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Instruments
    • 7.1.3. Reagents & Kits
    • 7.1.4. Software & Services

8. Core Clinical Molecular Diagnostics Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 8.1.2. Polymerase Chain Reaction (PCR)
    • 8.1.3. Next-Generation Sequencing (NGS)
    • 8.1.4. In Situ Hybridization
    • 8.1.5. Microarray
    • 8.1.6. Isothermal Nucleic Acid Amplification Technology (INAAT)

9. Core Clinical Molecular Diagnostics Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Hospitals & Clinics
    • 9.1.3. Diagnostic Laboratories
    • 9.1.4. Research Institutes
    • 9.1.5. Academic Institutions

10. Core Clinical Molecular Diagnostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Core Clinical Molecular Diagnostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Core Clinical Molecular Diagnostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Core Clinical Molecular Diagnostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Core Clinical Molecular Diagnostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Core Clinical Molecular Diagnostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Core Clinical Molecular Diagnostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
    • 11.2.2. Agilent Technologies, Inc.
    • 11.2.3. bioMerieux SA
    • 11.2.4. Bio-Rad Laboratories, Inc.
    • 11.2.5. Cepheid (A Danaher Company)
    • 11.2.6. Danaher Corporation
    • 11.2.7. Genomic Health, Inc. (Exact Sciences)
    • 11.2.8. Hologic, Inc.
    • 11.2.9. Illumina, Inc.
    • 11.2.10. Luminex Corporation
    • 11.2.11. Myriad Genetics, Inc.
    • 11.2.12. PerkinElmer, Inc.
    • 11.2.13. QIAGEN N.V.
    • 11.2.14. Roche Diagnostics
    • 11.2.15. Siemens Healthineers AG
    • 11.2.16. Thermo Fisher Scientific Inc.
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us